Jackson Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,711
Closed -$2.06M 99
2017
Q3
$2.06M Buy
14,711
+778
+6% +$106K 0.56% 44
2017
Q2
$1.88M Buy
13,933
+1,559
+13% +$191K 0.6% 43
2017
Q1
$1.55M Sell
12,374
-92
-0.7% -$11K 0.56% 45
2016
Q4
$1.43M Buy
12,466
+77
+0.6% +$8.57K 0.56% 47
2016
Q3
$1.24M Sell
12,389
-384
-3% -$41.6K 0.47% 49
2016
Q2
$1.26M Sell
12,773
-597
-4% -$61.8K 0.47% 51
2016
Q1
$1.36M Sell
13,370
-343
-3% -$35.3K 0.53% 45
2015
Q4
$1.47M Sell
13,713
-326
-2% -$37.7K 0.58% 46
2015
Q3
$1.52M Buy
14,039
+319
+2% +$39.6K 0.54% 55
2015
Q2
$1.58M Sell
13,720
-1,934
-12% -$221K 0.53% 56
2015
Q1
$1.8M Sell
15,654
-219
-1% -$26.2K 0.58% 53
2014
Q4
$1.78M Buy
+15,873
New +$1.67M 0.58% 55

Other funds holding CELG

Jackson Wealth Management's CELG Position: Q4 2017 in Review

Jackson Wealth Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 14,711 shares — an estimated $2.06M sold.

Jackson Wealth Management first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $2.06M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Jackson Wealth Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Jackson Wealth Management sold 14,711 Celgene Corp shares in Q4 2017, an estimated $2.06M.
  • Jackson Wealth Management first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
  • Jackson Wealth Management's Celgene Corp position peaked at $2.06M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Jackson Wealth Management's 13F filing for Q4 2017, filed 5 Feb 2018.